Drawing for Serial No. 86264547

USPTO serial 86264547

Serial No. 86264547

Reviewed by CopyMark Law Group

Reg. 4687451Status 710
Filing date
Status date
Registration date
Feb 17, 2015
Examiner
PENDLETON, CAROLYN A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 86264547?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1221 Avenue of the AmericasTrademark DepartmentNew York, NY 10020

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of disorders and diseases in, generated by or acting on, the central nervous system; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposesSECTION 8 - CANCELLED—
009Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical trials and tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; application software (APP) for information and interaction, namely, information in the field of research and treatment of central nervous system diseases and disordersSECTION 8 - CANCELLED—
035Consumer information in the field of research and treatment of central nervous system diseases and disordersSECTION 8 - CANCELLED—
041Educational services, namely, providing classes, seminars and workshops in the fields of research and development, science, clinical trials and tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; training services in the field of research and development, science, clinical trials and tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention provided electronically, on-line, via cable and Internet; providing on-line non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical trials and tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; arranging and conducting of in-person expert educational forums in the form of seminars, conferences, symposia, workshops and courses in the field of research and treatment of central nervous system diseases and disordersSECTION 8 - CANCELLED—
042Providing a website featuring technology that enables users to access, upload and share data and information in the field of research and development, science, clinical trials and tests, diagnostic medicine, pharmaceuticals, disorders, diseases, treatments and preventionSECTION 8 - CANCELLED—
044Psychiatry and psychology services; advice related to medical and pharmaceutical preparations; medical clinical services; medical treatment for psychiatric and neurological diseases and disorders; therapeutic treatment services for individuals suffering from psychiatric and neurological disorders and diseases, namely, counseling in the field of psychiatry and neurology; healthcare and medical services for the treatment of central nervous system disorders and diseases; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; on-line non-downloadable software applications (APP) to find or recognize symptoms of depression; medical information; providing on-line medical data and record analysis services designed to provide patients and clients customized information, also including information related to medicine, diagnosis, therapeutic issues and medical management and dosesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2021C8..CANCELLED SEC. 8 (6-YR)—
Jul 29, 2021ES7STEAS SECTION 7 SURRENDER RECEIVED—
Feb 17, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 2, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 2, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 28, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 28, 2014ALIEASSIGNED TO LIE—
Oct 16, 2014ALIEASSIGNED TO LIE—
Oct 16, 2014ALIEASSIGNED TO LIE—
Oct 16, 2014ALIEASSIGNED TO LIE—
Oct 9, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2014ALIEASSIGNED TO LIE—
Sep 29, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2014DOCKASSIGNED TO EXAMINER—
Jun 12, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 13, 2014MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 12, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 1, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance